• Over 20 years of experience in investment banking • Previously worked at JP Morgan Chase and Goldman Sachs • BS and MBA from Harvard University
Mr. Wang has 25 years of investment banking experience and is widely recognized as one of the pioneers in China's investment banking industry. He founded CEC Capital Group (formerly known as China eCapital Group) in 2000 and is now chairman and CEO of the firm. Under his leadership, CEC Capital has emerged as a leading private investment bank and asset management firm with a core focus on the TMT, consumer and healthcare sectors. At CEC Capital, Mr. Wang has overseen closing of over 300 transactions with total deal value exceeding RMB120 billion. Mr. Wang started his investment banking career at Goldman Sachs in 1994. Prior to founding CEC Capital, he had spent the previous three years with the Global M&A Group of JP Morgan, where he was responsible for developing and executing a number of large M&A transactions in the Asia-Pacific region. Mr. Wang has a bachelor degree in economics from Harvard College and an MBA from Harvard Business School. He has published extensively on economic and finance subjects in leading Chinese financial newspapers and magazines, and has close to 5 million followers on social media platform Sina Weibo, China’s Twitter.
• Over 20 years of experience in investment banking and the healthcare industry • Previously worked at Merck and Accenture • BS in Mechanical Engineering and MBA from U.C. Berkeley
Ms. Hong is a founding partner for CEC Capital Group, and leads the healthcare industry group. Under her guidance, CEC Capital has emerged as a leader in the healthcare banking sector with the largest specialized team covering pharma/biotech, medtech, services, and digital healthcare. Notable clients include Arrail Dental, Berry Genomics, China Medical Diagnostics Corporation, Righton Bio, Sino-Kor Hospital, and Reach Surgical. CEC Capital also has a strong cross-border practice, having worked in the past with several multinational companies including Zimmer, Charles River, and Teva. With an increasing interest in China outbound investment, CEC Capital has opened an office in the US and Ms. Hong will be leading this cross-border effort. Prior to joining CEC Capital, Ms. Hong was a Manager for Accenture’s (formerly Andersen Consulting) Strategic Services practice in San Francisco. Before receiving her MBA, Ms. Hong worked as an engineer for Merck and worked on several plant start-ups, including a technology transfer project in China for a recombinant Hepatitis B vaccine, and for Merck’s launch of Crixivan, a protease inhibitor for HIV. Ms. Hong has both her MBA and BS in Mechanical Engineering from UC Berkeley.
• Over 10 years of experience in investment banking, start-up management and venture capital investment • Previously worked at Bear Stearns, 21Vianet, Keytone Ventures, and IDG • BS in Finance and Information Systems from New York University
As one of CEC Capital’s earliest partners, Mr. Jin has led many influential financing and M&A projects since the company’s early days. Mr. Jin started his career in 1998 at Bear Stearns, working on the financing and overseas listing of Chinese Internet companies. He then joined 21Vianet as their vice president, where he was responsible for the company’s business development, products, and financing. From 2003 to 2007, after Mr. Jin joined CEC Capital and under his leadership, CEC Capital completed a series of innovative financing transactions and helped establish CEC Capital’s position as a market leader. While he has shifted his focus to high-tech venture investment since 2007, Mr. Jin has remained deeply involved in the business of CEC Capital. In 2016, he began serving as a partner of CEC’s RMB fund. Mr. Jin holds BS degrees in Finance and Information Systems from New York University’s Stern School of Business.
• Over 10 years of experience in investment management • Previously worked at FountainVest Partners and the New York City Employee Retirement System • BS from New York University Stern School of Business and LLM from Peking University Law School
Mr. Xu is a partner of CEC Capital and is the Managing Partner of CEC Future Industry Private Equity Fund. In his over ten-year career as a professional investor, Mr. Xu has managed more than USD 4 billion globally. He started his investment career in 2006 at the New York City Employee Retirement System, which managed USD 220 billion, and was responsible for their emerging market private equity investments. Before joining CEC Capital, Mr. Xu worked at FountainVest Partners, one of the largest private equity funds in China. Mr. Xu holds a Bachelor’s degree from New York University’s Stern School of Business and an LLM from Peking University Law School.
• Over 10 years of investment and management experience in entertainments, sports, TMT, and the consumer industry • Previously worked at Fosun, Roland Berger and General Mills • BS from Ohio State University and MBA from Oxford University
As a veteran investor, Mr. Wang has rich experience in domestic and foreign investment, management consulting and business operations. His career began at the US-based General Mills, where he participated in and completed the largest M&A transactions in the company’s history. After returning to China, he worked at Roland Berger as a senior consultant in consumer goods, healthcare and other industries. In 2010, Mr. Wang joined CEC Capital and during the four years spent here, he completed financing and M&A transactions worth over RMB 10 billion before leaving as the senior director of M&A. In 2014, he joined the Fosun Group where he served as the Executive Director of International Development Department and China Momentum Fund and led a number of investments in Infront Sports & Media, DTZ Zadelhoff, and other companies. In 2016, he returned to CEC and as a founder of the RMB fund, where he serves as a fund partner and member of the Investment Committee. Mr. Wang holds an MBA from Oxford University and a BS degree in Management from Ohio State University.
• Over 10 years of experience in direct investment and M&A • Previously worked at Sanpower Group and lashou.com • Master in Monetary Banking and Finance from Birmingham University and EMBA from CKGSB
Mr. Zhang has over 10 years of experience in direct investment in capital markets and M&A. He previously worked at JLL, Boxin Capital and Sanpower Group and completed pre-IPO private equity investments in A-share listed companies such as Sanfo Outdoors and Raisecom. He also participated in and completed Nanjing Cenbest’s acquisition of House of Fraser, the largest department store group in Britain and Sanpower’s acquisition of Brookstone, a US-based specialty retailer. During his tenure in Sanpower, he led the establishment of M&A funds for several listed companies. Mr. Zhang holds a Master’s degree in Monetary Banking and Finance from Birmingham University and an EMBA degree from Cheung Kong Graduate School of Business.
• Over 10 years of experience in investment banking • Previously worked at IBD, CICC and PASC • Master in Finance and BS in Economics from Peking University
Mr. Song has more than ten years of experience in investment banking, having served ten of the Fortune 500 companies. He has engaged in financing and M&A transactions with a total value exceeding RMB 250 billion. Mr. Song started his investment banking career at CICC in 2006. During that time, he was responsible for executing IPO, equity financing, bond financing and M&A projects for major clients, such as China Construction Bank, Agriculture Bank of China, Postal Savings Bank of China, China Minsheng Bank, Jiangxi Copper Corporation, China Guangdong Nuclear Power Holding Co., Ltd and Jiangsu Guoxin Investment Group Limited. Mr. Song joined Ping An Securities in 2013 and served as the Executive Director of Investment Banking Department and General Manager of Sichuan branch from 2013 to 2016. During that period, he was responsible for providing investment banking services for several large and medium-sized state-owned enterprises and private enterprises, and served on the company’s Management Committee. Mr. Song holds dual Bachelor degrees in Science and Economics and a Master degree of finance from Peking University.
• Over 10 years experience in investment banking • Previously worked at IBD, CITIC Securities • Master in Finance and Financial Management from Berlin School of Economics and Law
Mr. Li once served as the Senior Vice President at CITIC Securities and participated in various projects covering refinancing, overseas M&A, asset restructuring and financial advising services. Since 2012, he has been focusing on the medical and healthcare industry. He has provided a full range of investment banking services for many distinguished companies such as Dianhong Pharmaceutical, Yiling Pharmaceutical, Yifeng Pharmacy, Shineway Pharmaceutical, Jointown Pharmaceutical and Huahai Pharmaceutical. During his tenure in CITIC, he also directly promoted and participated in the establishment and implementation of several fund and asset management programs. Mr. Li holds a Master’s degree in International Finance and Finance Management from the Berlin School of Economics and Law, and is fluent in German and English.
• Over 10 years of internet, game & investment experience • Previously worked at Perfect World and China Venture Labs • MBA from Fordham University and Peking University
Mr. Chen joined CEC Capital in June 2012 and is mainly responsible for private equity financing and M&A in games, advertising, VR/AR and other industries. During his tenure, he has led the team in completing a number of financing and M&A transactions, including the split-up of Baidu Video, merger of Chinese online movie ticket firms WePiao and Gewara, and Zhongnan Culture’s acquisition of zs-e.com. Before joining CEC Capital, Mr. Chen was the Director of Investment and Business Development at Perfect World, a leading game and film company in China. Mr. Chen also previously worked as a manager at China Venture Labs, a venture capital fund, and at OrangeGames, a leading game company where he was responsible for strategy and market research. Mr. Chen holds an MBA degree from Fordham University and Peking University.
• Over 15 years of operational experience in healthcare • Previously worked as the regional General Manager and Head of Market Access and Public Policy at Merck Sharp & Dohme (China) Limited • BS in Pharmacy from Shandong Medical University and EMBA from China Europe International Business School
Ms. Cai has 18 years of operational and investment experience in the health care and pharmaceutical industries. She participated in the restructuring of teams to facilitate Schering-Plough (China)’s acquisition of Organon and Merck’s acquisition of Schering-Plough (China). She was once the regional General Manager and Head of Market Access and Public Policy at Merck, where she was responsible for market access and public policy development, as well as product launching, sales, marketing, and distribution channels. Ms. Cai graduated from the Department of Pharmacy of Shandong Medical University and holds an EMBA degree from China Europe International Business School. In addition, she is also an International Certified Management Consultant.
• Over 10 years of experience in industrial investment • Previously worked at the Zhongfa Group, Luye Pharma Group, and Sam Woo • MBA from Bowling Green State University, Master in Chemistry from Case Western Reserve University, BS and Master in Chemistry from Nankai University
Mr. Peng has over 10 years of experience in domestic and foreign industrial investment. He once served as the Deputy General Manager of the Zhongfa Group, where he was responsible for-strategic investments in internationalized industries. Simultaneously, he developed a variety of projects in health care at home and abroad with Zhongfa’s subsidiaries - Union Life, Wing Tai Properties Limited and Yerui Pharma. Mr. Peng was also once the Director of International Investment at the Luye Pharma Group, where he was responsible for international investment, M&A and product licensing. During his tenure, he facilitated Luye Pharma’s acquisition of Acina’s Transdermal Drug Delivery (TDS) business in 2016. Mr. Peng holds an MBA from Bowling Green State University, a Master’s Degree in Chemistry from Case Western Reserve University, and BS and Master’s degrees in Chemistry from Nankai University.
• Over 17 years of experience in TMT investment banking • Previously worked at Bank of America Merrill Lynch, TPG Capital (TPG Asia), and Montgomery & Co. • BA in Economics from Yale University
Dan Chen brings to CEC Capital over 18 years of investment banking, private equity and corporate development experience in TMT industries, and has been involved in over $5 billion worth of transactions during his career. Dan currently leads origination and execution of cross-border US - Asia M&A and capital raising mandates for clients in the internet software and services space as well as the telecom, media, and entertainment industries. Dan was a Managing Director at Siemer & Associates prior to its acquisition by CEC Capital. He was also a member of the investment team at TPG Capital. Prior to joining Siemer & Associates, Dan was also Vice President in the media and software groups at Montgomery & Co.. Dan began his career in 1999 as a technology M&A banker at Merrill Lynch & Co. in New York and San Francisco. Mr. Chen holds a Bachelors of Economics from Yale University.
• Over 20 years of experience in investment banking • Previously worked at Deutsche Bank, Macquarie Capital, Nomura International and Lehman Brothers, Inc. • BS in Engineering of Shanghai Jiaotong University, MBA of Fuqua School Of Business, Duke University
Mr. Shao has nearly twenty years of experience in investment banking, with a core focus on TMT. He was responsible for executing a number of deals for clients, including large internet companies like Tencent, Alibaba, Baidu and Xiaomi. Prior to joining CEC Capital, he was the MD of Deutsche Bank and Macquarie capital in Hongkong. He was in charge of TMT investment banking of the Greater China, leading a number of IPOs, private financing and cross-border transactions, including TAL, Bao Chun and LINEKONG. Prior to this, Mr. Shao worked in New York and Hongkong, with Lehman Brothers and Nomura International. He has been engaged in IBD and research for many years. Mr. Shao has BS in Engineering of Shanghai Jiaotong University, MBA of Fuqua School Of Business, Duke University.